期刊文献+

血清乙型肝炎病毒表面抗原大蛋白检测的临床意义与评价 被引量:7

Evaluation and clinical significance of HBV large protein (LHBs) in diagnosis of hepatitis B
原文传递
导出
摘要 目的通过对乙型病毒性肝炎(乙肝)患者血清中乙肝表面抗原大蛋白(LHBs)、HBVDNA、乙肝前S1(PreSl)及传统的乙肝两对半的检测与平行比较研究,探讨LHBs用于临床诊断乙型肝炎的意义。方法检测385例乙肝患者的血清标本,LHBs、PreSl及乙肝两对半采用酶联免疫方法,HBVDNA检测采用实时荧光定量PCR法。结果307份HBVDNA阳性标本中LHBs的阳性率(86.97%)明显高于PreSl的阳性率(49.5%),两者差异有统计学意义(P〈0.05);LHBs含量与HBVDNA拷贝数呈正相关性,r=0.935;HBeAg阴性标本中LHBs的检出率为76.92%,比较HBVDNA的检出率(67.95%)无统计学意义;PreSl的检出率(45.73%)则明显低于LHBs和HBVDNA。结论乙肝患者血清中LHBs表达与HBVDNA拷贝数呈正相关,两者的检出率与符合率均高于PreSl,LHBs检测可以用于反映乙肝患者病毒复制的血清免疫学指标。 Objective To explore the significance of HBV large protein (LHBs) in diagnosis of hepatitis B, we detected the LHBs, HBV DNA, PreS1 and other hepatitis B viral markers (HBV M ) in the serum of patients infected with HBV. Methods HBV DNA was quantitatively detected using RT-PCR, LHBs, PreS1 and HBV M were analyzed by ELISA in totally 385 serum samples. Results There was a significant difference between the positive rate of LHBs ( 86.97 % ) and PreS1 (49.5 % ) in the 307 serum positive for HBV DNA ( P 〈 0.05). There was a correlation between the levels of LHBs and the logarithm of HBV DNA ( r = 0.935). In the serum specimens of patients negative for HBeAg, there was no significant difference between the positive rate of LHBs (76.92%) and the HBV DNA (67.95%), but the positive rate of PreS1 (45.73%) was lower than that of LHBs or HBV DNA. Conclusion There was a close correlation between the copies of HBV DNA and the levels of LHBs, both the positive rate and the coincidence rate of LBHs and HBV DNA were higher than those of PreS1. LHBs can reflect the replication status of HBV.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2007年第3期241-243,共3页 Chinese Journal of Experimental and Clinical Virology
关键词 肝炎表面抗原 乙型 肝炎病毒 乙型 DNA 蛋白质S 肝炎 乙型 Hepatitis B surface antigens Hepatitis B virus DNA Protein S Hepatitis B
  • 相关文献

参考文献4

二级参考文献7

  • 1杨海林,张祖传,曹蕙婷,徐谐,李光地,崔大敷,汪垣.抗乙型肝炎病毒表面抗原preS1(20-47)多抗的制备、性质和应用[J].生物化学与生物物理学报,1994,26(2):145-151. 被引量:6
  • 2骆抗先.实验感染模型[A].骆抗先主编.乙型肝炎基础和临床:第2版[C].北京:人民卫生出版社,2001.74-84.
  • 3Brunet to MR,ste mler ME,etal.A new hepatitis B vires strain in patients with severe anti-HBe positivechronic hepatitis[J].B J Hepatol,1990,10(5):258~262.
  • 4Doong sl,Tsai CH,Schinazi RF,et al.Inhibition of the replication of hepatit is B virus in vitro by 21,31-dideoxy-31-thiacygideine and related analogues[J].Proc Natl Acid Sci USA,1999,88:8495~8499.
  • 5刘尚仁.慢性乙型肝炎患者循环免疫复合物检测的临床分析[J].上海免疫学杂志,1994,14(1):52-52.
  • 6徐宜为.免疫检测技术[M]科学出版社,1991.
  • 7陈压西,郭树华,齐珍元,黄爱龙.拉米夫定联合泛昔洛韦抗鸭乙型肝炎病毒的实验研究[J].中华肝脏病杂志,2001,9(4):209-211. 被引量:25

共引文献58

同被引文献54

  • 1Hua Liu Hui Cao Zhi-Yong Wu.Isolation of Kupffer cells and their suppressive effects on T lymphocyte growth in rat orthotopic liver transplantation[J].World Journal of Gastroenterology,2007,13(22):3133-3136. 被引量:21
  • 2Wei FY,Tomizawa K.CDK5:a potential herapeutic target for the treatment of neurodegenerative diseases and diabetes mellitus[J].Mini Rev Med Chem,2007,7 (10):1070-1074.
  • 3Neuman KF,Rojo L,Navarrete LP,et al.Insulin resistance and Alzheimer's disease:molecular links &clinical implications[J].Curr Alzheimer Res,2008,5:438-447.
  • 4Sanghera DK,Ortega L,Hab S,et al.Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs:PPARG2 (Pro12Ala),IGF2BP2,TCF7L2 and FTO variants confer a significant risk[J].BMC Med Genet,2008,9:59.
  • 5Wang X,Ching YP,Lam WH,et al.Identification of common protein association region in neuronal Cdk5 activator[J].J Biol Chen,2000,13:31763-31769.
  • 6Ching YP,Qi Z,Wang JH,et al.Cloning of three novel neuronal Cdk5 activator binding proteins[J].Gene,2000,25:285-294.
  • 7Zeggini E,Weedon MN,lingren CM,et al.Relication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes[J].Science,2007,316:1336-1341.
  • 8Arao M,Murase K,Kusakabe A,et al.Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus[J].J Gastroenterol,2003,38:355-360.
  • 9Koike K.Hepatitis C as a metabolic disease:Implication for the pathogenesis of NASH[J].Hepatol Res,2005,33:145-150.
  • 10Chan HL, Sung JJ. Hepatocellular carcinoma and hepatitis B vi- rus. Semin Liver Dis, 2006, 26(2) : 153-161.

引证文献7

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部